Loading clinical trials...

COMPLETEDPhase 2NCT05041426

Letermovir for CMV Prevention After Lung Transplantation

This is an interventional, open-label, single center, pilot study with historical controls to test the efficacy of letermovir (LET) for the prevention of CMV infection and disease in adult lung transp...

Lead sponsor: Fernanda P Silveira, MD, MS•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

NCT07516379 · Lung Transplant, End Stage Lung Disease, and more

RECRUITING

Infectious Complications in Hematological Patients Under Treatment With Bispecific Antibodies.

NCT07609576 · Lymphoma Neoplasms, Myeloma Multiple, and more

RECRUITINGEARLY Phase 1

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

NCT04469842 · Lung Transplant; Complications

RECRUITINGPhase 2

Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

NCT06476132 · Lung Transplant

RECRUITINGPhase 1

Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension

NCT06770023 · Lung Transplant, Pulmonary Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 9, 2026Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment15

Start dateDec 2021

Last updatedApr 9, 2026

Condition

Lung Transplant CMV

Locations shown

UPMC

Pittsburgh, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 9, 2026Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions